Max Löhning

Max Löhning

Auto-generated profile, based on publicly available information

Max Löhning

German Rheumatology Research Center (DRFZ), a Leibniz Institute, Pitzer Laboratory of Osteoarthritis Research, Berlin, Germany

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2014 in Nature
Verified
Journal Article
Open access
PDF file
CSChris Schiering
Chris Schiering
TKThomas Krausgruber
Thomas Krausgruber
ACAgnieszka Chomka
Agnieszka Chomka
AFAnja Fröhlich
Anja Fröhlich
KAKrista Adelmann
Krista Adelmann
FPFiona Powrie
Fiona Powrie
The alarmin interleukin-33 is constitutively expressed at barrier sites and released in response to tissue damage; here, the IL-33 receptor ST2 is shown to be preferentially expressed on colonic regulatory T cells, where it promotes regulatory T-cell function and adaptation to the inflammatory tissue environment. Interleukin-33 (IL-33) is an 'alarmin', constitutively expressed at barrier sites and released in response to tissue damage where it recruits components of the repair response. This study in two mouse models of colitis shows that the IL-33 receptor ST2 is preferentially expressed on colonic regulatory T cells, where it promotes regulatory T-cell function and adaptation to the inflammatory tissue environment. IL-33 is negatively regulated by the pro-inflammatory cytokine IL-23, suggesting that the balance between IL-33 and IL-23 could be an important controller of intestinal immune responses. FOXP3+ regulatory T cells (Treg cells) are abundant in the intestine, where they prevent dysregulated inflammatory responses to self and environmental stimuli. It is now appreciated that Treg cells acquire tissue-specific adaptations that facilitate their survival and function1; however, key host factors controlling the Treg response in the intestine are poorly understood. The interleukin (IL)-1 family member IL-33 is constitutively expressed in epithelial cells at barrier sites2, where it functions as an endogenous danger signal, or alarmin, in response to tissue damage3. Recent studies in humans have described high levels of IL-33 in inflamed lesions of inflammatory bowel disease patients4,5,6,7, suggesting a role for this cytokine in disease pathogenesis. In the intestine, both protective and pathological roles for IL-33 have been described in murine models of acute colitis8,9,10,11, but its contribution to chronic inflammation remains ill defined. Here we show in mice that the IL-33 receptor ST2 is preferentially expressed on colonic Treg cells, where it promotes Treg function and adaptation to the inflammatory environment. IL-33 signalling in T cells stimulates Treg responses in several ways. First, it enhances transforming growth factor (TGF)-β1-mediated differentiation of Treg cells and, second, it provides a necessary signal for Treg-cell accumulation and maintenance in inflamed tissues. Strikingly, IL-23, a key pro-inflammatory cytokine in the pathogenesis of inflammatory bowel disease, restrained Treg responses through inhibition of IL-33 responsiveness. These results demonstrate a hitherto unrecognized link between an endogenous mediator of tissue damage and a major anti-inflammatory pathway, and suggest that the balance between IL-33 and IL-23 may be a key controller of intestinal immune responses.

1 January 1997 in Nature
Verified
Journal Article
Closed access
PDF file
FAFrank Austrup
Frank Austrup
DVDietmar Vestweber
Dietmar Vestweber
EBEric Borges
Eric Borges
MLMax Löhning
Max Löhning
RBRolf Bräuer
Rolf Bräuer
AHAlf Hamann
Alf Hamann

1 January 2000 in Immunity
Verified
Journal Article
Closed access
WOWenjun Ouyang
Wenjun Ouyang
MLMax Löhning
Max Löhning
ZGZhiguang Gao
Zhiguang Gao
MAMario Assenmacher
Mario Assenmacher
SRSheila Ranganath
Sheila Ranganath
KMKenneth M. Murphy
Kenneth M. Murphy

9 June 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MLMax Löhning
Max Löhning
ASArne Stroehmann
Arne Stroehmann
ACAnthony J. Coyle
Anthony J. Coyle
JGJane L. Grogan
Jane L. Grogan
SLSteven Lin
Steven Lin
TKThomas Kamradt
Thomas Kamradt
T helper (Th) cells can be categorized according to their cytokine expression. The differential induction of Th cells expressing Th1 and/or Th2 cytokines is key to the regulation of both protective and pathological immune responses. Cytokines are expressed transiently and there is a lack of stably expressed surface molecules, significant for functionally different types of Th cells. Such molecules are of utmost importance for the analysis and selective functional modulation of Th subsets and will provide new therapeutic strategies for the treatment of allergic or autoimmune diseases. To this end, we have identified potential target genes preferentially expressed in Th2 cells, expressing interleukin (IL)-4, IL-5, and/or IL-10, but not interferon-γ. One such gene, T1/ST2, is expressed stably on both Th2 clones and Th2-polarized cells activatedin vivoorin vitro. T1/ST2 expression is independent of induction by IL-4, IL-5, or IL-10. T1/ST2 plays a critical role in Th2 effector function. Administration of either a mAb against T1/ST2 or recombinant T1/ST2 fusion protein attenuates eosinophilic inflammation of the airways and suppresses IL-4 and IL-5 productionin vivofollowing adoptive transfer of Th2 cells.

9 January 2011 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
VCVan Trung Chu
Van Trung Chu
AFAnja Fröhlich
Anja Fröhlich
GSGudrun Steinhauser
Gudrun Steinhauser
TSTobias Scheel
Tobias Scheel
TRToralf Roch
Toralf Roch
CBClaudia Berek
Claudia Berek

24 February 2012 in Science
Verified
Journal Article
Closed access
PDF file
WBWeldy V. Bonilla
Weldy V. Bonilla
AFAnja Fröhlich
Anja Fröhlich
KSKarin Senn
Karin Senn
SKSandra Kallert
Sandra Kallert
MFMarylise Fernandez
Marylise Fernandez
DPDaniel D. Pinschewer
Daniel D. Pinschewer
Sound the Alarm: When small protein fragments or nucleic acids derived from an invading pathogen are detected by pattern recognition receptors on immune cells, the innate immune response is triggered. This event activates cells of the adaptive immune system, and together, both responses clear the infection. Infections also induce the release of “danger-associated molecular patterns,” or alarmins, from the host as a result of tissue damage. Whether these are also important for the ensuing immune response is less clear. Bonilla et al. (p. 984 , published online 2 February) report that the alarmin, interleukin-33, is required for optimal cytotoxic CD8 + T cells responses and antiviral immunity in mice. In virus-infected mice deficient in IL-33 or its receptor, IL-33 is essential for signaling CD8 + T cells to expand, produce multiple cytokines and acquire cytotoxic capabilities. These results showed that endogenous material, independently of pathogen-derived molecules, are also required for antiviral immunity.